Le Lézard
Classified in: Ebola virus, Health, Science and technology, Covid-19 virus

Global Patient Temperature Monitoring Market Set for Remarkable Growth as Demand Surges for Advanced Monitoring Devices - ResearchAndMarkets.com


The "Patient Temperature Monitoring - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

The global market for Patient Temperature Monitoring, estimated at US$5.8 billion in 2022, is poised for significant growth, projected to attain a revised size of US$12.2 billion by 2030, with an impressive CAGR of 9.6% over the analysis period spanning from 2022 to 2030.

Within the report's analysis, Handheld Temperature Monitoring Devices are projected to record an impressive 11.1% CAGR, reaching a market size of US$8.2 billion by the end of the analysis period. Growth in the Table Top Temperature Monitoring Devices segment is estimated at 8% CAGR for the next 8-year period.

U.S. Market Estimated at $1.8 Billion, China Forecasted to Grow at 11.6% CAGR

In the U.S., the Patient Temperature Monitoring market is estimated at US$1.8 billion in 2022. Meanwhile, China, the world's second-largest economy, is forecasted to reach a projected market size of US$1.8 billion by 2030, exhibiting a robust CAGR of 11.6% over the analysis period from 2022 to 2030. Other noteworthy geographic markets include Japan and Canada, each expected to grow at 7.6% and 8.3%, respectively, over the 2022-2030 period. Within Europe, Germany is forecasted to grow at an approximate CAGR of 9%.

Key Competitors in the Patient Temperature Monitoring Market

The report identifies key competitors in the Patient Temperature Monitoring market, including American Diagnostic Corporation, Actherm, Inc., Asia Connection Co., Ltd., American Thermal Instruments, Amico Corporation, Abronn FZE, AME WORLDWIDE, AViTA Corporation, B.Well Swiss AG, Babybelle Asia Ltd., Beaba UK Ltd., AndesFit System Limited, 3J`SHealthcare Group, LLC, Alicn Medical(Shenzhen),Inc., Beybi Plastik Fabrikasi Sanayi AS, and many others.

What's New in the Report?

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

For more information about this report visit https://www.researchandmarkets.com/r/jfdrd3

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


These press releases may also interest you

at 09:05
Smart Meter, the leading supplier of Cellular Remote Patient Monitoring (RPM)tm solutions, has introduced a new version of the iGlucose, its patented cellular-connected glucose meter used by over 200,000 people with diabetes since 2019. The...

at 09:00
Today, the Honourable Gary Anandasangaree, Minister of Crown-Indigenous Relations; the Honourable Patty Hajdu, Minister of Indigenous Services and Minister responsible for FedNor; the Honourable Dan Vandal, Minister of Northern Affairs; and the...

at 08:05
GE HealthCare today unveiled SIGNA MAGNUS, an FDA 510(k) pending head-only magnetic resonance (MR) scanner designed to explore advancements in neuroscience, which have been restricted by the performance limitations of conventional whole-body MR...

at 07:00
To mark National Hospice Palliative Care Week, the Quebec Coalition for Palliative Care Access (the Coalition) is proud to celebrate the positive impact of palliative care on the well-being of people with life-limiting illness. Palliative care is...

at 06:00
A native born and trained Brazilian oncologist is in the forefront of a new era in the treatment of cancer patients with cutting edge proton therapy medical technology developed in Israel by P-Cure. "It is my dream to be able to bring the P-Cure...

4 mai 2024
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced results from a new analysis of the ATLAS trial, which estimates using Kaplan Meier...



News published on and distributed by: